Did Your Broker Recommend a Non-Traded BDC? Major Redemption Problems Are Emerging in 2026 Non-traded BDC redemption losses are becoming a serious concern for investors.
If your financial advisor or broker recommended that you invest in a non-traded Business Development Company (BDC) such as Blackstone's BCRED, Blue Owl, KKR, Apollo, or Ares Capital, you may have a right to recover your losses. In fact, those suffering from non-traded BDC redemption losses may have unique legal rights.
What Is Happening With BDCs Right Now?
Non-traded BDCs have been marketed to retail investors for years as a "safe" alternative to traditional fixed-income products — a way to earn above-average yields without the daily volatility of the stock market. What brokers often failed to tell their clients is that these investments are illiquid, meaning that getting your money back is not as simple as selling a stock.
In 2025 and into 2026, a wave of redemption requests has exposed the structural fragility of many of these products:
- Blackstone Private Credit Fund (BCRED) returned $3.7 billion — approximately 7.9% of its total assets — in Q1 2026 alone, far exceeding its standard 5% redemption limit.
- Blue Owl Technology Income Corp (OTIC) reported redemptions of 15.4% in Q4 2025.
- Blue Owl Capital Corporation II suspended its tender offers entirely and began selling assets just to meet investor demands.
- KKR (K-FIT) received redemption requests equal to 6.3% of its fund in early 2026.
- Apollo capped redemptions on its non-traded BDC after investor exit requests surged past allowable limits.
- Ares Capital capped redemptions at 5% after facing requests totaling 11.6% — more than double what it was willing to honor.
When a fund cannot satisfy redemption requests, investors who need access to their money are left waiting — or are told they simply cannot get out. Moreover, some investors experience non-traded BDC redemption losses due to these delays and restrictions.
Why This May Be Your Broker's Fault
FINRA rules require brokers to recommend only investments that are suitable for their clients. Non-traded BDCs are inherently illiquid, high-fee products that carry significant risk. They are generally not appropriate for retirees, conservative investors, or anyone who may need access to their funds within a reasonable timeframe.
If your broker recommended a non-traded BDC without fully explaining the liquidity restrictions, the redemption gates, the risk that your exit requests could be capped or denied, or the potential for declining net asset values, that recommendation may constitute a FINRA violation.
Brokers earn significantly higher commissions — sometimes 7% to 10% — for selling non-traded BDCs compared to traditional investment products. That financial incentive can lead advisors to place clients in products that benefit the broker far more than the investor.
Your Rights as an Investor
You may be entitled to recover your losses through FINRA arbitration if your broker:
- Recommended a non-traded BDC without understanding your financial needs or risk tolerance
- Misrepresented the liquidity of the investment
- Failed to disclose redemption caps, gates, or restrictions
- Concentrated too much of your portfolio in illiquid alternative investments
Contact a Securities Attorney Today
If you have invested in BCRED, Blue Owl, KKR K-FIT, Apollo, or Ares Capital and are having trouble getting your money back — or if you believe your broker put you in these investments without fully explaining the risks — contact Soreide Law Group today for a free consultation. To sum up, if you are facing non-traded BDC redemption losses, legal advice may help you recover funds.
We represent investors nationwide in FINRA arbitration and have helped clients recover millions of dollars in investment losses. There are no upfront fees. We only get paid if you recover.
📞 Call us today or fill out our contact form to speak with a securities attorney.
The information in this post is for general informational purposes only and does not constitute legal advice. Past results do not guarantee future outcomes.